TFF3 and breast cancer: The high and correlated expression of CA12 and TFF3 in estrogen receptor-positive BC may play a role in reducing the tumor’s sensitivity to chemotherapy drugs such as adriamycin and docetaxel, which in turn can negatively impact the efficacy of NAC [26].